Naresh Verma

Naresh Verma completed his PhD at the Department of Microbiology, University of Sydney. He then pursued his research interests in microbial pathogenesis and vaccine development in post-doctoral fellowship appointments at the Karolinska Institute in Sweden and Howard Hughes Medical Institute at Stanford University, U.S.A. After five years of postdoctoral training, he returned to Australia to take up a faculty position at the Australian National University. He was admitted as a fellow of the Australian Society for Microbiology (FASM) in 2005.

Selected publications

  • Ashok, D, Taheri, M, Garg, P, Webb, D, Parajuli, P, Wang, Y, Funnell, B, Taylor, B, Tscharke, D, Tsuzuki, T, Verma, N, Tricoli, A, and Nisbet, D (2022) Shielding Surfaces from Viruses and Bacteria with a Multiscale Coating. Advanced Science.
  • Sen, T and Verma, NK (2022) Functional role of YnfA, an Efflux Transporter in Resistance to Antimicrobial Agents in Shigella flexneri. Antimicrobial Agents and Chemotherapy.
  • Rajput, M and Verma, NK (2022) Identification of critical residues of O-antigen-modifying O-acetyltransferase B (OacB) of Shigella flexneri. BMC Molecular and Cell Biology. 23, 16 (2022).
  • Sen, T and Verma, NK (2022)YfiB: An Outer Membrane Protein Involved in the Virulence of Shigella flexneri. Microorganisms.2022, 10(3), 653.
  • Parajuli, P, Minh, B and Verma, NK (2020) Newly emerged serotype 1c of Shigella flexneri: multiple origins and changing drug-resistance landscape. Genes, 11, 1042;
  • Sen, T and Verma, NK (2020) Functional Annotation and Curation of Hypothetical Proteins Present in A Newly Emerged Serotype 1c of Shigella flexneri: Emphasis on Selecting Targets for Virulence and Vaccine Design Studies. Genes 23;11(3):340. doi: 10.3390/genes11030340.
  • Somasiri, P, Behm, CA, Adamski, M, Wen J and Verma, NK (2019) Transcriptional response of Caenorhabditis elegans when exposed to Shigella flexneri. Genomics.
  • Parajuli, P, Deimel LP and Verma NK (2019) Genome Analysis of Shigella flexneri Serotype 3b Strain SFL1520 Reveals Significant Horizontal Gene Acquisitions Including a Multidrug Resistance Cassette. Genome Biol Evol. 11(3):776-785.
  • Parajuli, P, Rajput, MI and Verma NK (2019) Plasmids of Shigella flexneri serotype 1c strain Y394 provide advantages to bacteria in the host. BMC Microbiology 29;19(1):86.
  • Parajuli, P, Adamski M and Verma NK (2017) Bacteriophages are the major drivers of Shigella flexneri serotype 1c genome plasticity: a complete genome analysis. BMC Genomics 18:722.
  • Tang SS, Carlin NIA, Talukder KA, Cam PD and Verma NK (2016) Shigella flexneri serotype 1c derived from serotype 1a by acquisition of gtrIC gene cluster via a bacteriophage. BMC Microbiology 16:127.
  • Jakhetia R and Verma NK (2015) Identification and Molecular Characterisation of a Novel Mu-Like Bacteriophage, SfMu, of Shigella flexneri. PLoS One 10(4):e0124053.
  • Jakhetia R, Marri A, Ståhle J, Widmalm G, Verma NK (2014) Serotype-conversion in Shigella flexneri: identification of a novel bacteriophage, Sf101, from a serotype 7a strain. BMC Genomics 15(1):742.
  • George DT, Behm CA, Hall DH, Mathesius U, Rug M, Nguyen KC, Verma NK (2014) Shigella flexneri Infection in Caenorhabditis elegans: Cytopathological Examination and Identification of Host Responses. PLoS One 9(9):e106085
  • George, D., Mathesius, U., Behm, C. and Verma, N.K. (2014) The periplasmic enzyme, AnsB, of Shigella flexneri modulates bacterial adherence to host epithelial cells. PLoS One 9(4):e94954
  • Jakhetia, R., Talukder, K.A. and Verma, N.K. (2013) Isolation, characterization and comparative genomics of bacteriophage SfIV: a novel serotype converting phage from Shigella flexneri. BMC Genomics 14:677.
  • Rusden, A.D., Stephenson, D.P. and Verma, N.K. (2013) Topological Investigation of Glucosyltransferase V in Shigella flexneri using the Substituted Cysteine Accessibility Method. Biochemistry 16;52(15):2655-2661.
  • Thanweer F and Verma, N.K. (2012) Identification of critical residues of the serotype modifying O-acetyltransferase of Shigella flexneri. BMC Biochem.15: 13(1):13-21.
  • Linterman, M., Beaton, L., Yu, D., Ramiscal, R., Srivastava, M., Hogan, J., Verma, N.K., Smyth M., Rigby, R. and Vinuesa, C.G. (2010) IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. Journal of Experimental Medicine 207: 353 - 363.
  • Stagg, R., Tang, Swee-Seong, Carlin, N.,Talukder, K., Cam, P. and Verma, N. K. (2009) A novel glucosyltransferase involved in O-antigen modification of Shigella flexneri serotype 1c. Journal of Bacteriology 191: 6612 - 6617.
  • Korres, H. and Verma, N. K. (2006) Identification of essential loops and residues of Glucosyltransferase V (GtrV) of Shigella flexneri. Molecular Membrane Biology 23: 407-419.
  • Lehane, A.M., Korres, H. and Verma N.K. (2005) Bacteriophage-encoded glucosyltransferase GtrII of Shigella flexneri : membrane topology and identification of critical residues. Biochemical J., 389: 137-143.
  • Korres, H. and Verma, N. K. (2004) Topological analysis of glucosyltransferase GtrV of Shigella flexneri by a dual reporter system and identification of a unique reentrant loop. Journal of Biological Chemistry 279: 22469-22476.
  • Jennison, A.V. and Verma, N.K. (2004) Shigella flexneri infection: pathogenesis and vaccine development. FEMS Microbiology Reviews 28: 43-58.
  • Allison, G.E., Angeles, D., Tran-Dinh, N. and Verma, N.K. (2002) The complete genome sequence of SfV, a serotype-converting temperate bacteriophage of Shigella flexneri. Journal of Bacteriology 184: 1974-1987.
  • Allison, G.E. and Verma, N.K. (2000) Serotype-converting bacteriophages and O-antigen modification in Shigella flexneri. Trends in Microbiology 8: 17-23.

All publications

Naresh supervises PhB, ASC's and other undergraduate research projects.